Epstein Secrets

blog.corn/lawfare-podcast-briefings-schmiefings> (9/2) podcast, Benjamin Wittes discusses the decision to end broad election security briefings with David Priess, "a former CIA briefer who used to do briefings like this, and Margaret Taylor, a former congressional staffer who used to consume briefings like t

escent Plasma. In an op-ed for the New York Times <https://www.nytimes.corn/2020/09/02/opinion/coronavirus-convalescent-plasma.html> (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate eviden

information are scanty at best." In a Lawfare (9/2) podcast, Benjamin Wittes discusses the decision to end broad election security briefings with David Priess, "a former CIA briefer who used to do briefings like this, and Margaret Taylor, a former congressional staffer who used to consume briefings like th

initive answer." Lamas: Insufficient Clinical Data For Efficacy Or Safety Of Convalescent Plasma. In an op-ed for the New York Times (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evide

information are scanty at best." In a Lawfare (9/2) podcast, Benjamin Wittes discusses the decision to end broad election security briefings with David Priess, "a former CIA briefer who used to do briefings like this, and Margaret Taylor, a former congressional staffer who used to consume briefings like th

initive answer." Lamas: Insufficient Clinical Data For Efficacy Or Safety Of Convalescent Plasma. In an op-ed for the New York Times (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evide